Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure King, B., Ko, J., Piraccini, B., Shimomura, Y., Dutron, Y., Wu, W., Yang, F., Holzwarth, K., Chiasserini, C., Sinclair, R. MOSBY-ELSEVIER. 2023: AB220

View details for Web of Science ID 001078492800867